For example, over-expression of S100A2, S100A3, S100A6, S100A8/A9, and S100A11 is related to several types of cancer, whereas other types of cancer are characterized by the under-expression of these same proteins (Chen et al., 2014). Here, S100A11 is linked to cancer.